What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? (Q46626941)

23 December 2017

title

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? (English)

1 reference

23 December 2017

1 reference

23 December 2017

Kelly-Anne Phillips

1 reference

23 December 2017

Bettina Meiser

object named as

Bettina Meiser

1 reference

23 December 2017

Belinda Thewes

1 reference

23 December 2017

Vlatka M Duric

1 reference

23 December 2017

Martin R Stockler

1 reference

23 December 2017

Alan Taylor

1 reference

23 December 2017

Robin Stuart-Harris

1 reference

23 December 2017

Nicholas Wilcken

1 reference

23 December 2017

Sue Anne McLachlan

1 reference

23 December 2017

Jane Beith

1 reference

23 December 2017

Frances Boyle

1 reference

23 December 2017

Michael L Friedlander

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

Lancet Oncology Commission

published in

1 reference

23 December 2017

volume

1 reference

23 December 2017

issue

1 reference

23 December 2017

page(s)

581-588

1 reference

23 December 2017

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Life after breast cancer: understanding women's health-related quality of life and sexual functioning

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Breast irradiation postlumpectomy: development and evaluation of a decision instrument

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Framing of outcome and probability of recurrence: breast cancer patients' choice of adjuvant chemotherapy (ACT) in hypothetical patient scenarios

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preferences for interferon alfa in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Someone to live for: social well-being, parenthood status, and decision-making in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Screening for anxiety and depression in cancer patients: the effects of disease and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Optimism, coping, and health: assessment and implications of generalized outcome expectancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preference for cancer therapy: an overview of measurement approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Stability of patients' preferences for chemotherapy: the impact of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Decision-making in early breast cancer: guidelines and decision tools

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

10.1016/S1470-2045(05)70254-0

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017